Announced

SPIE to acquire a 87% stake in Otto Life Science Engineering from Equistone.

Synopsis

SPIE, a multi-technical services in the areas of energy and communications company, agreed to acquire a 87% stake in Otto Life Science Engineering, a specialised provider of EPC services, from Equistone, a private equity firm. Financial terms were not disclosed. “The acquisition of OTTO LSE enables SPIE to accelerate on the very dynamic EPC market for pharmaceutical and biotech customers with a reputable player benefitting from a very high added value positioning. The unique know-how of the company, combined with such positioning, largely contributes to the significant and recurring level of profitability. This operation will strengthen SPIE’s position, expertise and client portfolio in Industry Services in Germany. We are pleased to welcome the Management of OTTO LSE and its team to SPIE,” Gauthier Louette, SPIE Chairman and CEO.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US